PubMed:29576358
Annnotations
Zierdiyeerkenaili_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 528-530 | CI | denotes | PA |
| T10 | 2674-2677 | CI | denotes | PAS |
| T11 | 2946-2949 | CI | denotes | PAS |
| T12 | 3064-3067 | CI | denotes | PAS |
| T13 | 3333-3336 | CI | denotes | PAS |
| T14 | 34-51 | CI | denotes | phosphatidic acid |
| T15 | 509-526 | CI | denotes | phosphatidic acid |
| T16 | 501-503 | CI | denotes | PS |
| T17 | 481-499 | CI | denotes | phosphatidylserine |
| T18 | 11-29 | CI | denotes | phosphatidylserine |
| T19 | 405-408 | DP | denotes | PMS |
| T2 | 61-64 | CI | denotes | PAS |
| T20 | 113-116 | DP | denotes | PMS |
| T21 | 563-566 | DP | denotes | PMS |
| T22 | 658-661 | DP | denotes | PMS |
| T23 | 781-784 | DP | denotes | PMS |
| T24 | 1142-1145 | DP | denotes | PMS |
| T25 | 1547-1550 | DP | denotes | PMS |
| T26 | 2120-2123 | DP | denotes | PMS |
| T27 | 3092-3095 | DP | denotes | PMS |
| T28 | 3139-3142 | DP | denotes | PMS |
| T29 | 382-403 | DP | denotes | premenstrual syndrome |
| T3 | 541-544 | CI | denotes | PAS |
| T30 | 90-111 | DP | denotes | premenstrual syndrome |
| T31 | 875-882 | CI | denotes | placebo |
| T32 | 144-151 | CI | denotes | placebo |
| T33 | 1692-1699 | CI | denotes | placebo |
| T34 | 1988-1995 | CI | denotes | placebo |
| T35 | 2240-2247 | CI | denotes | placebo |
| T36 | 2494-2501 | CI | denotes | placebo |
| T37 | 2782-2789 | CI | denotes | placebo |
| T38 | 842-851 | CI | denotes | 400 mg PA |
| T39 | 2976-2985 | CI | denotes | 400 mg PA |
| T4 | 651-654 | CI | denotes | PAS |
| T40 | 830-839 | CI | denotes | 400 mg PS |
| T41 | 2962-2971 | CI | denotes | 400 mg PS |
| T5 | 814-817 | CI | denotes | PAS |
| T6 | 1666-1669 | CI | denotes | PAS |
| T7 | 1714-1717 | CI | denotes | PAS |
| T8 | 2228-2231 | CI | denotes | PAS |
| T9 | 2457-2460 | CI | denotes | PAS |
yaoziqian_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 563-566 | DP | denotes | PMS |
| T14 | 651-654 | CI | denotes | PAS |
| T15 | 658-661 | DP | denotes | PMS |
| T16 | 781-784 | DP | denotes | PMS |
| T17 | 814-817 | CI | denotes | PAS |
| T19 | 842-851 | CI | denotes | 400 mg PA |
| T2 | 61-64 | CI | denotes | PAS |
| T21 | 875-882 | CI | denotes | placebo |
| T22 | 1142-1145 | DP | denotes | PMS |
| T23 | 1547-1550 | DP | denotes | PMS |
| T24 | 1666-1669 | CI | denotes | PAS |
| T25 | 1692-1699 | CI | denotes | placebo |
| T26 | 1714-1717 | CI | denotes | PAS |
| T27 | 1988-1995 | CI | denotes | placebo |
| T28 | 2120-2123 | DP | denotes | PMS |
| T29 | 2228-2231 | CI | denotes | PAS |
| T3 | 90-111 | DP | denotes | premenstrual syndrome |
| T30 | 2457-2460 | CI | denotes | PAS |
| T31 | 2494-2501 | CI | denotes | placebo |
| T32 | 2674-2677 | CI | denotes | PAS |
| T33 | 2782-2789 | CI | denotes | placebo |
| T34 | 2946-2949 | CI | denotes | PAS |
| T35 | 2962-2971 | CI | denotes | 400 mg PS |
| T36 | 2976-2985 | CI | denotes | 400 mg PA |
| T37 | 3064-3067 | CI | denotes | PAS |
| T38 | 3092-3095 | DP | denotes | PMS |
| T39 | 3139-3142 | DP | denotes | PMS |
| T4 | 113-116 | DP | denotes | PMS |
| T40 | 3333-3336 | CI | denotes | PAS |
| T41 | 830-839 | CI | denotes | 400 mg PS |
| T42 | 509-526 | CI | denotes | phosphatidic acid |
| T44 | 528-530 | CI | denotes | PA |
| T45 | 541-544 | CI | denotes | PAS |
| T46 | 11-29 | CI | denotes | phosphatidylserine |
| T47 | 481-499 | CI | denotes | phosphatidylserine |
| T48 | 34-51 | CI | denotes | phosphatidic acid |
| T49 | 501-503 | CI | denotes | PS |
| T5 | 382-403 | DP | denotes | premenstrual syndrome |
| T6 | 405-408 | DP | denotes | PMS |
| T50 | 144-151 | CI | denotes | placebo |
| T51 | 2240-2247 | CI | denotes | placebo |